Stock Alert: Amicus (FOLD) Trades 9.52% Higher June 23

Equities Staff  |

Amicus Therapeutics Inc (NASDAQ:FOLD) stock was among today's market movers, finishing trading up 9.52% to $10.93 on June 23.

5,425,377 shares traded hands compared to the 30-day daily average of 3,713,721 shares.

The company's stock has climbed 13.59% so far in 2022.

Amicus shares have fluctuated between $5.91 and $12.63 over the past twelve months.

The company expects its next earnings on 2022-08-04.

For technical charts, analysis, and more on Amicus visit the company profile.

About Amicus Therapeutics Inc

Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases.

To get more information on Amicus Therapeutics Inc and to follow the company's latest updates, you can visit the company's profile page here: Amicus Therapeutics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?



Market Movers

Sponsored Financial Content